|
ZNF597 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.377100E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.715800E-02 |
| Normal-vs-Stage2 |
3.972400E-02 |
| Normal-vs-Stage3 |
3.155200E-03 |
| Normal-vs-Stage4 |
5.447300E-04 |
| Stage1-vs-Stage2 |
4.550600E-01 |
| Stage1-vs-Stage3 |
9.763800E-02 |
| Stage1-vs-Stage4 |
3.433700E-02 |
| Stage2-vs-Stage3 |
6.542000E-01 |
| Stage2-vs-Stage4 |
5.454800E-01 |
| Stage3-vs-Stage4 |
8.367800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.210000E-02 |
| Normal-vs-AfricanAmerican |
3.914800E-01 |
| Normal-vs-Asian |
3.359600E-02 |
| Caucasian-vs-AfricanAmerican |
7.346400E-01 |
| Caucasian-vs-Asian |
6.908800E-01 |
| AfricanAmerican-vs-Asian |
5.485000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.704900E-03 |
| Normal-vs-Female |
1.198100E-02 |
| Male-vs-Female |
3.999400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.458300E-02 |
| Normal-vs-Age(41-60Yrs) |
2.728400E-02 |
| Normal-vs-Age(61-80Yrs) |
5.249800E-04 |
| Normal-vs-Age(81-100Yrs) |
4.716400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.254200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.463700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.272600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.574200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.778800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.856400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.779540E-03 |
| Classical-VS-Follicular |
1.443460E-03 |
| Classical-VS-Other |
1.658790E-01 |
| Classical-VS-Normal |
2.422200E-01 |
| Tall-VS-Follicular |
9.940800E-01 |
| Tall-VS-Other |
8.700800E-01 |
| Tall-VS-Normal |
6.425200E-04 |
| Follicular-VS-Other |
9.084600E-01 |
| Follicular-VS-Normal |
3.771000E-04 |
| Other-VS-Normal |
4.050300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.101320E-03 |
| Normal-vs-N1 |
2.348400E-02 |
| N0-vs-N1 |
8.691600E-01 |
|
|
